Creative Medical Technology (CELZ) vs Evogene (EVGN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Creative Medical Technology is the larger company by market cap ($6.5 million vs $6.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CELZ | EVGN |
|---|---|---|
| Share price | $0.8604 | $0.3985 |
| Market cap | $6.53M | $6.30M |
| 1-day change | -2.45% | -2.95% |
| EPS (TTM) | $-2.07 | $-1.55 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.25 | $1.49 |
| 52-week low | $0.62 | $0.35 |
| Distance from 52-week high | -86.23% | -73.26% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +2224.50% | +439.52% |
| Average volume | 6.77M | 1.50M |
| Shares outstanding | 7.59M | 15.80M |
| Employees | 4 | 38 |
| Sector | Health Care | Industrials |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Agricultural Chemicals |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- The two companies sit in different sectors: Creative Medical Technology in Health Care and Evogene in Industrials.
About Creative Medical Technology
CELZ stock →Creative Medical Technology Holdings, Inc., a commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction, and FemCelz for the treatment of loss of genital sensitivity and dryness.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 4 employees
About Evogene
EVGN stock →Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Europe, and Africa. It operates through three segments: Agriculture, Human Health, and Industrial Applications.
Industrials · Agricultural Chemicals · 38 employees
CELZ vs EVGN FAQ
Which is bigger, Creative Medical Technology or Evogene?
Creative Medical Technology (CELZ) is larger, with a market capitalization of $6.53M compared with $6.30M for Evogene (EVGN).
Are Creative Medical Technology and Evogene in the same industry?
No. Creative Medical Technology is in the Health Care sector, while Evogene is in Industrials.